Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems

Area of Science:

• Oncology
• Genetics
• Immunology

Background:

• PTEN (Phosphatase and tensin homolog) is a crucial tumor suppressor gene.
• Loss of PTEN function is implicated in various human cancers.
• The specific roles of PTEN in different tissues and its interaction with the immune system require further elucidation.

Purpose of the Study:

• To investigate the role of PTEN/Mmac1 heterozygosity in tumor development across multiple organs.
• To examine the association of tumor development with lymphoid tissue.
• To understand the impact of PTEN loss on apoptosis, proliferation, and immune cell organization.

Main Methods:

• Generation and analysis of Pten/Mmac1+/- heterozygous mice.
• Histopathological examination of neoplasms in various organs (endometrium, liver, prostate, GI tract, thyroid, thymus).
• Analysis of wild-type allele loss, lymphoid tissue association, and immune cell populations (B cells, T cells, macrophages).

Main Results:

• Pten/Mmac1+/- mice developed neoplasms in multiple organs.
• Gastrointestinal tumors were associated with gut lymphoid tissue, while others were not.
• Nonneoplastic lymphoid hyperplasia was observed due to defective apoptosis in B cells and macrophages.
• Disrupted organization of B and T cells in peripheral lymphoid tissues.

Conclusions:

• PTEN regulates both apoptosis and cell proliferation.
• PTEN functions as a "landscaper" tumor suppressor in the gastrointestinal tract.
• PTEN acts as a "gatekeeper" tumor suppressor in organs like the endometrium, liver, prostate, and thyroid.